Epstein–Barr virus sustains tumor killers

ArticleinNature medicine 14(11):1148-50 · December 2008with3 Reads
Impact Factor: 27.36 · DOI: 10.1038/nm1108-1148 · Source: PubMed

    Abstract

    The immune system's response to a latent and ubiquitous virus is harnessed to kill tumors in a small study of humans. The approach overcomes a major barrier to effective tumor immunotherapy—generating a sustained immune response (pages 1264–1270).